Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

—Is it asthma? Is it chronic obstructive pulmonary disease? In a genome-wide association study, researchers in the U.K. have determined signals that are associated with both diseases. Here are the ...

Background: Asthma and COPD can significantly affect patients and pose a substantial economic burden for both patients and managed-care plans. This study compares utilization outcomes in patients with ...

ABP Live Doc Talk: Most of the patients come into the clinic with complaints of asthma, particularly when they have chronic ...

—According to findings of a large study of patient care in England and Wales, hospitalized patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma have different ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. COPD exacerbations went down by 51% in patients with ...

March 11, 2011 — A combination of 4 blood proteins may serve as biomarkers to help clinicians distinguish patients with asthma from those with chronic obstructive pulmonary disease (COPD), Australian ...

Adults receiving early-stage chronic obstructive pulmonary disease or asthma care from a pulmonologist had lower respiratory-related hospitalization and emergency department visit rates than those ...

Please provide your email address to receive an email when new articles are posted on . In a cohort of individuals with respiratory symptoms, 21% had undiagnosed COPD or asthma. Researchers found ...

A diagnostic algorithm was evaluated for its ability to gauge the presence of asthma or chronic obstructive pulmonary disease (COPD), in a new analysis. An asthma/chronic obstructive pulmonary disease ...

Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD. That's the hope of a new line of research underway at the University of California, Davis.

Add Yahoo as a preferred source to see more of our stories on Google. Lead author Dr. Shawn Aaron, a senior scientist and lung specialist at The Ottawa Hospital in Ottawa, Ontario, Canada, described ...